Dixian Luo

Dr. Dixian Luo


Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2024 in Advanced Materials
Verified
Journal Article
Open access
PDF file
QZQingshuang Zou
Qingshuang Zou
KLKe Liao
Ke Liao
GLGuangchao Li
Guangchao Li
XHXin Huang
Xin Huang
YZYongwei Zheng
Yongwei Zheng
QLQuan Liu
Quan Liu
The infiltration and cytotoxicity of chimeric antigen receptor (CAR)‐T cells are crucial for effective elimination of solid tumors. While metallo‐immunotherapy is a promising strategy that can activate the antitumor immunity, its role in promoting CAR‐T cell therapy remains elusive. The first single‐element nanomaterial based on chromium nanoparticles (Cr NPs) for cancer photo‐metallo‐immunotherapy has been reported previously. Herein, an extended study using biodegradable polydopamine as a versatile carrier for these nanoparticles, enabling synergistic CAR‐T cell therapy, is reported. The results show that these nanocomposites with or without further encapsulation of the anticancer drug alpelisib can promote the CAR‐T cell migration and antitumor effect. Upon irradiation with near‐infrared light, they caused mild hyperthermia that can “warm” the “cold” tumor microenvironment (TME). The administration of B7‐H3 CAR‐T cells to NOD severe combined immunodeficiency gamma mice bearing a human hepatoma or PIK3CA‐mutated breast tumor can significantly inhibit the tumor growth after the induction of tumor hyperthermia by the nanocomposites and promote the secretion of serum cytokines, including IL‐2, IFN‐γ, and TNF‐α. The trivalent Cr3+ ions, which are the major degradation product of these nanocomposites, can increase the CXCL13 and CCL3 chemokine expressions to generate tertiary lymphoid structures (TLSs) in the tumor tissues, facilitating the CAR‐T cell infiltration.

24 December 2024 in Advanced Science
Verified
Journal Article
Open access
QZQingshuang Zou
Qingshuang Zou
AQAilin Qiu
Ailin Qiu
YHYan He
Yan He
EXEvelyn Y. Xue
Evelyn Y. Xue
LWLujie Wang
Lujie Wang
Dennis K.P NgDennis K.P Ng
Dennis K.P Ng
Transition metal carbides, nitrides, and carbonitrides (MXenes) have emerged as a promising class of 2D materials that can be used for various applications. Recently, a new form of high‐entropy MXenes has been reported, which contains an increased number of elemental species that can increase the configurational entropy and reduce the Gibbs free energy. The unique structure and composition lead to a range of intriguing and tunable characteristics. Herein, the fabrication of high‐entropy MXene TiVNbMoC3Tx (T = surface terminations) with a layer of polydopamine is reported, followed by immobilization of a phthalocyanine‐based fluorophore for imaging and the peptide sequence QRHKPREGGGSC for targeting the epidermal growth factor receptor (EGFR) overexpressed in cancer cells. The resulting nanocomposite exhibits high biocompatibility and superior photothermal property. Upon laser irradiation at 808 nm, the light‐to‐heat conversion efficiency is up to 56.1%, which is significantly higher than that of conventional 2D materials. In vitro studies show that these nanosheets could be internalized selectively into EGFR‐positive cancer cells and effectively eliminate these cells mainly through photothermal‐induced apoptosis. Using 4T1 tumor‐bearing mice as an animal model, the nanosheets could accumulate at the tumor and effectively eradicate the tumor upon laser irradiation without causing noticeable adverse effects to the mice.

29 November 2025 in Scientific Reports
Verified
Journal Article
Open access
PDF file
SCShang Chen
Shang Chen
JZJianling Zeng
Jianling Zeng
KGKe Gong
Ke Gong
YLYaru Liu
Yaru Liu
SLShoubin Long
Shoubin Long
DLDixian Luo
Dixian Luo
Early diagnosis of breast cancer (BC) remains pivotal for enhancing patient outcomes, yet current imaging modalities face inherent limitations. This retrospective study, encompassing 1366 BC patients and 1186 healthy controls (HC) from Shenzhen Nanshan People’s Hospital (2022–2025), developed and validated a serum tumor marker-based predictive model to address this gap. Eight markers—CEA, AFP, CA199, CA242, CA15-3, CA125, FER, and NSE—were analyzed, with multivariate logistic regression identifying AFP, CA242, CA15-3, and NSE as independent diagnostic predictors. The resulting four-marker panel demonstrated robust performance, achieving an AUC of 0.90 (95% CI: 0.89–0.92) with 77.3% sensitivity and 89.7% specificity in the development cohort (n = 1535), and sustained efficacy in validation (AUC = 0.82, 87.5% sensitivity, 72.8% specificity; n = 761). The model effectively stratified early-stage (T1/T2: 86.49% accuracy) versus advanced-stage (T3/T4: 92.00%) tumors, lymph node involvement (N0: 86.49%; N+: 88.00%), metastatic status (M0: 87.32%; M+: 85.71%), and molecular subtypes (Luminal A: 91.33%; Luminal B: 82.35%; HER2+: 84.61%; triple-negative: 87.75%). Notably, longitudinal risk score trends correlated with therapeutic response, declining in remission and rising with progression. These findings collectively highlight the model’s dual utility as a high-accuracy diagnostic tool for early BC detection and a dynamic biomarker for monitoring treatment efficacy. This novel model may provide an auxiliary approach in current screening paradigms, underscoring its transformative potential in oncology practice.

27 February 2026 in Food Chemistry
Verified
Journal Article
Open access
YLYingjun Lu
Yingjun Lu
XYXiaojing Yu
Xiaojing Yu
HLHe Li
He Li
JSJingwen Sun
Jingwen Sun
Yan ChenYan Chen
Yan Chen
HZHongwei Zhang
Hongwei Zhang
Wheat gluten is a primary cause of food-related disorders such as wheat allergy and celiac disease, yet its reliable quantification in processed foods remains challenging. To address this, we developed a data-independent acquisition (DIA) proteomic screening approach to discover heat-resistant marker peptides, identifying QYEQQPVVPSK, LEGSDALSTR, and VNVPLYR as thermostable signature peptides for quantifying high molecular weight glutenin (HMW-G) and low molecular weight glutenin (LMW-G). Their specificity was confirmed by BLAST analysis against other cereal proteomes. Based on these peptides, we developed a UHPLC-MS/MS method, which demonstrated exceptional sensitivity with limits of detection (LOD) of 0.081 mg/kg for HMW-G and 0.049 mg/kg for LMW-G and limits of quantification (LOQ) of 0.4 mg/kg and 0.244 mg/kg, respectively, in potato chips and surimi. This method, representing the first application of thermostable glutenin peptides, has been successfully applied to complex processed products, providing a robust tool for allergen detection.

24 August 2026 in Cancer Cell International
Verified
Journal Article
Open access
PDF file
SCShang Chen
Shang Chen
AQAilin Qiu
Ailin Qiu
QHQian Hu
Qian Hu
QLQuan Liu
Quan Liu
YZYaming Zhang
Yaming Zhang
DLDixian Luo
Dixian Luo
The metabolic landscape of breast cancer is intricately associated with patient outcomes, with metabolic reprogramming serving as a crucial determinant. Ne